A recent report showed that KYNU expression correlated with poor overall survival in lung adenocarcinoma, by promoting tumor immunosuppression through the induction of tumor-infiltrated Tregs accompanied by a concordant increase of PD1 and PD-L1 protein levels [38]. The gene discussed is CD274; the disease is neoplasm.